242 related articles for article (PubMed ID: 24135855)
21. Mebendazole targets essential proteins in glucose metabolism leading gastric cancer cells to death.
da Silva EL; Mesquita FP; Aragão DR; de Sousa Portilho AJ; Marinho AD; de Oliveira LLB; Lima LB; de Moraes MEA; Souza PFN; Montenegro RC
Toxicol Appl Pharmacol; 2023 Sep; 475():116630. PubMed ID: 37473966
[TBL] [Abstract][Full Text] [Related]
22. Mebendazole, an antiparasitic drug, inhibits drug transporters expression in preclinical model of gastric peritoneal carcinomatosis.
Celestino Pinto L; de Fátima Aquino Moreira-Nunes C; Soares BM; Burbano RMR; de Lemos JAR; Montenegro RC
Toxicol In Vitro; 2017 Sep; 43():87-91. PubMed ID: 28606429
[TBL] [Abstract][Full Text] [Related]
23. Biotransformation of anthelmintics and the activity of drug-metabolizing enzymes in the tapeworm Moniezia expansa.
Prchal L; Bártíková H; Bečanová A; Jirásko R; Vokřál I; Stuchlíková L; Skálová L; Kubíček V; Lamka J; Trejtnar F; Szotáková B
Parasitology; 2015 Apr; 142(5):648-59. PubMed ID: 25373326
[TBL] [Abstract][Full Text] [Related]
24. The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma.
Simbulan-Rosenthal CM; Dakshanamurthy S; Gaur A; Chen YS; Fang HB; Abdussamad M; Zhou H; Zapas J; Calvert V; Petricoin EF; Atkins MB; Byers SW; Rosenthal DS
Oncotarget; 2017 Feb; 8(8):12576-12595. PubMed ID: 28157711
[TBL] [Abstract][Full Text] [Related]
25. Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers.
Meco D; Attinà G; Mastrangelo S; Navarra P; Ruggiero A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674870
[TBL] [Abstract][Full Text] [Related]
26. Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.
Druzhyna N; Szczesny B; Olah G; Módis K; Asimakopoulou A; Pavlidou A; Szoleczky P; Gerö D; Yanagi K; Törö G; López-García I; Myrianthopoulos V; Mikros E; Zatarain JR; Chao C; Papapetropoulos A; Hellmich MR; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):18-37. PubMed ID: 27521834
[TBL] [Abstract][Full Text] [Related]
27. A Comparison between the Effects of Albendazole and Mebendazole on the Enzymatic Activity of Excretory / Secretory Products of Echinococcus granulosus Protoscoleces in Vitro.
Adnani Sadati SJ; Farahnak A; Molaei Rad MB; Golestani A; Eshraghiyan MR
Iran J Public Health; 2016 Feb; 45(2):223-9. PubMed ID: 27114987
[TBL] [Abstract][Full Text] [Related]
28. Interaction of benzimidazole anthelmintics with Haemonchus contortus tubulin: binding affinity and anthelmintic efficacy.
Lubega GW; Prichard RK
Exp Parasitol; 1991 Aug; 73(2):203-13. PubMed ID: 1889474
[TBL] [Abstract][Full Text] [Related]
29. Albendazole and mebendazole uptake by isolated enterocytes.
Villaverde C; Alvarez AI; del Estal JL; Prieto JG
Dev Pharmacol Ther; 1992; 19(1):27-31. PubMed ID: 1307343
[TBL] [Abstract][Full Text] [Related]
30. Mebendazole induces apoptosis via C-MYC inactivation in malignant ascites cell line (AGP01).
Pinto LC; Mesquita FP; Soares BM; da Silva EL; Puty B; de Oliveira EHC; Burbano RR; Montenegro RC
Toxicol In Vitro; 2019 Oct; 60():305-312. PubMed ID: 31207347
[TBL] [Abstract][Full Text] [Related]
31. Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition.
Blom K; Rubin J; Berglund M; Jarvius M; Lenhammar L; Parrow V; Andersson C; Loskog A; Fryknäs M; Nygren P; Larsson R
BMC Res Notes; 2019 Apr; 12(1):234. PubMed ID: 31010428
[TBL] [Abstract][Full Text] [Related]
32. Molecular modeling: a tool for predicting anthelmintic activity in vivo.
Lipkowitz KB; McCracken RO
Parasitol Res; 1993; 79(6):475-9. PubMed ID: 8415561
[TBL] [Abstract][Full Text] [Related]
33. Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells.
Wang X; Lou K; Song X; Ma H; Zhou X; Xu H; Wang W
Toxicol Appl Pharmacol; 2020 Jun; 396():115001. PubMed ID: 32277947
[TBL] [Abstract][Full Text] [Related]
34. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
[TBL] [Abstract][Full Text] [Related]
35. An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice.
Liu CS; Zhang HB; Lei W; Zhang CW; Jiang B; Zheng Q; Yin JH; Han XM
Parasit Vectors; 2014 Dec; 7():589. PubMed ID: 25491386
[TBL] [Abstract][Full Text] [Related]
36. Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing.
Rubin J; Mansoori S; Blom K; Berglund M; Lenhammar L; Andersson C; Loskog A; Fryknäs M; Nygren P; Larsson R
Oncotarget; 2018 Jul; 9(56):30805-30813. PubMed ID: 30112108
[TBL] [Abstract][Full Text] [Related]
37. Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer.
Zhang L; Bochkur Dratver M; Yazal T; Dong K; Nguyen A; Yu G; Dao A; Bochkur Dratver M; Duhachek-Muggy S; Bhat K; Alli C; Pajonk F; Vlashi E
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):195-207. PubMed ID: 30196056
[TBL] [Abstract][Full Text] [Related]
38. Vinblastine and antihelmintic mebendazole potentiate temozolomide in resistant gliomas.
Kipper FC; Silva AO; Marc AL; Confortin G; Junqueira AV; Neto EP; Lenz G
Invest New Drugs; 2018 Apr; 36(2):323-331. PubMed ID: 28852916
[TBL] [Abstract][Full Text] [Related]
39. Mebendazole exhibits potent anti-leukemia activity on acute myeloid leukemia.
He L; Shi L; Du Z; Huang H; Gong R; Ma L; Chen L; Gao S; Lyu J; Gu H
Exp Cell Res; 2018 Aug; 369(1):61-68. PubMed ID: 29750898
[TBL] [Abstract][Full Text] [Related]
40. Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies.
Francisca PA; Javier LF; Guadalupe PH; Fernanda GM; Nelly C; Helgi JC; Iliana GH; Susana RI
Acta Trop; 2020 Feb; 202():105238. PubMed ID: 31669532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]